One-year outcome using cyanoacrylate glue to ablate truncal vein incompetence: A Singapore VenaSeal™ real-world post-market evaluation study (ASVS).
Tjun Yip TangCharyl Jq YapShereen Xue Yun SoonSze L ChanEdward Tc ChokeTze T ChongPublished in: Phlebology (2021)
CAG remains a safe and efficacious venous ablative technology at 12 months and is associated with a high rate of target vein occlusion and sustained QoL improvement.
Keyphrases